Richard Vance Smith

Dr. Richard Vance Smith


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
VMVikas Mehta
Vikas Mehta
SGSANJAY GOEL
SANJAY GOEL
RKRafi Kabarriti
Rafi Kabarriti
DCDaniel Cole
Daniel Cole
MGMendel Goldfinger
Mendel Goldfinger
Amit VermaAmit Verma
Amit Verma
Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer, lactate dehydrogenase, and lactate in multivariate analysis. Age-adjusted CFRs in patients with cancer compared with noncancer patients at our institution and New York City reported a significant increase in case fatality for patients with cancer. These data suggest the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. Significance: COVID-19 in patients with cancer is associated with a significantly increased risk of case fatality, suggesting the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. This article is highlighted in the In This Issue feature, p. 890

8 January 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
RSRichard Vance Smith
Richard Vance Smith
BSBradley A. Schiff
Bradley A. Schiff
CSCatherine Sarta
Catherine Sarta
SHStéphane Hans
Stéphane Hans
DBDaniel Brasnu
Daniel Brasnu

1 April 1999 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
TKTamar Kotz
Tamar Kotz
SASuzanne Abraham
Suzanne Abraham
JBJonathan J. Beitler
Jonathan J. Beitler
SWScott Wadler
Scott Wadler
RSRichard Vance Smith
Richard Vance Smith
SEVERE DYSPHAGIA is a frequent and debilitating consequence of head and neck cancer resection.1-7 Patients who have undergone major resections for cancer of the oral cavity, oropharynx, hypopharynx, and larynx experience varying degrees of swallowing difficulty. The nature and extent of the swallowing disability are related to the site and size of the tumor and the method of treatment,8 with increasing size of the resection being associated with a greater impairment of swallowing.8,9 The type and method of reconstruction also have a substantial effect on deglutition and associated neurologic deficits.

26 April 2016 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
EDEugenie Du
Eugenie Du
TOThomas J. Ow
Thomas J. Ow
YLYung‐Tai Lo
Yung‐Tai Lo
AGAdam Gersten
Adam Gersten
BSBradley A. Schiff
Bradley A. Schiff
RSRichard Vance Smith
Richard Vance Smith

1 November 2002 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DRDukhee Rhee
Dukhee Rhee
BWBruce M. Wenig
Bruce M. Wenig
RSRichard Vance Smith
Richard Vance Smith

8 March 2023 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
KWKaruna Wongtangman
Karuna Wongtangman
BABoudewijn Aasman
Boudewijn Aasman
SGShweta Garg
Shweta Garg
AWAnnika S. Witt
Annika S. Witt
AHArshia A. Harandi
Arshia A. Harandi
PRPriya Ramaswamy
Priya Ramaswamy